Roche · 4 days ago
Access Strategy Leader
South San Francisco, CA
Full-time
Onsite
Senior Level, Lead/Staff
8+ years expRoche is dedicated to advancing science and ensuring access to healthcare for all. The Access Strategy Leader will play a crucial role in developing and implementing strategies that ensure broad and sustainable patient access to innovative healthcare offerings, while collaborating with cross-functional teams to align access considerations with commercialization efforts.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Serve as the Primary Point of Contact (PPOC) for the unified Access team, championing the Access/Payers perspective on the Commercial Leadership Teams and ensuring their needs and challenges are prioritized
Lead the development and implementation of holistic access strategies that are scalable, feasible, and balance patient access with sustainable pricing and reimbursement across markets
Assemble, synthesize, and distill access insights from research, affiliate feedback, and GA intelligence into a compelling Disease Area (DA) Access strategic brief to shape and refine the commercialization strategy
Ensure that the commercialization strategy seamlessly embeds access insights and deliverables by the unified Access team, and support the adoption of the access strategy in key markets by guiding local execution (providing Access Amplifier guidance and Objection handler support)
Ensure alignment with Access partners so that registrational trials and other clinical and non-clinical evidence packages are supportive of the overall access strategy, including the Integrated Evidence Package (IEP)
Co-create access materials and outputs that incorporate diverse stakeholder perspectives (such as HTA bodies, Payers, Policy Makers, Governments, Patients, Caregivers, and Society) to successfully support reimbursement submission and Access processes globally, and actively engage externally (e.g., Medical/Commercial Ad Board, Congresses)
Develop access assessments to inform investment decisions, valuations, and asset strategies for pipeline products and business development opportunities, and empower and coach GA partners to deliver key insights for integrated access assessments, strategies, plans, and their implementation
Qualification
Required
A Bachelor's Degree (life sciences, health economics, marketing, or medical), MBA, or other relevant Graduate or Postgraduate Degrees is required
Significant pharmaceutical customer-facing experience, preferably in both global and country-level positions, or experience working within a cross-functional or integrated commercial team globally and locally
You must have 8+ years of access experience in the pharmaceutical or related industry, with multidisciplinary experience within and beyond Access being an advantage
The ability to work in a matrix organization, lead diverse teams to achieve common goals, and demonstrate strong knowledge of the drug development and commercialization process, as well as the current and future external environment
The capability to understand complex scientific issues, translate them into effective access and business strategies, operate in ambiguity, and deliver impactful messages/strategic recommendations to a broad range of stakeholders, with deep knowledge of the Access landscape (e.g., US, China, EU4, UK, Canada)
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
10001+ employees
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Alan Hippe
Member of the Executive Board - Group CFO
Christine Bakan
Global Head and VP of Software and Bioinformatics, Next Generation Sequencing
Recent News
MarketScreener
2026-01-06
globalventuring.com
2026-01-06
MarketScreener
2026-01-05
Company data provided by crunchbase